Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8703645, 9 pages
http://dx.doi.org/10.1155/2016/8703645
Research Article

Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis

1Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russia
2Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
3Institute of Cytology and Genetics, Novosibirsk, Russia
4Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
5Martsinovsky Institute of Medical Parasitology and Tropical Medicine, Sechenov First Moscow State Medical University, Moscow, Russia

Received 11 December 2015; Revised 22 March 2016; Accepted 18 April 2016

Academic Editor: Birke Bartosch

Copyright © 2016 Alexander A. Andreev-Andrievskiy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Persson, “Rheumatoid arthritis and periodontitis—inflammatory and infectious connections. Review of the literature,” Journal of Oral Microbiology, vol. 4, Article ID 11829, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Balandraud, J. Roudier, and C. Roudier, “Epstein-Barr virus and rheumatoid arthritis,” Autoimmunity Reviews, vol. 3, no. 5, pp. 362–367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Álvarez-Lafuente, B. Fernández-Gutiérrez, S. de Miguel et al., “Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1357–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Malviya, S. Salemi, B. Laganà, A. P. Diamanti, R. D'Amelio, and A. Signore, “Biological therapies for rheumatoid arthritis: progress to date,” BioDrugs, vol. 27, no. 4, pp. 329–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Pelletier, T. S. Lepow, L. K. Billingham, M. P. Murphy, and R. M. Siegel, “New tricks from an old dog: mitochondrial redox signaling in cellular inflammation,” Seminars in Immunology, vol. 24, no. 6, pp. 384–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Ishibashi, “Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases,” Current Pharmaceutical Design, vol. 19, no. 35, pp. 6375–6381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. Sánchez-Barceló, M. D. Mediavilla, D. X. Tan, and R. J. Reiter, “Clinical uses of melatonin: evaluation of human trials,” Current Medicinal Chemistry, vol. 17, no. 19, pp. 2070–2095, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Elmali, O. Baysal, A. Harma, I. Esenkaya, and B. Mizrak, “Effects of resveratrol in inflammatory arthritis,” Inflammation, vol. 30, no. 1-2, pp. 1–6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. C. Rosenbaum, D. P. O'Mathúna, M. Chavez, and K. Shields, “Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis,” Alternative Therapies in Health and Medicine, vol. 16, no. 2, pp. 32–40, 2010. View at Google Scholar · View at Scopus
  10. P. H. Canter, B. Wider, and E. Ernst, “The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials,” Rheumatology, vol. 46, no. 8, pp. 1223–1233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Liberman, V. P. Topaly, L. M. Tsofina, A. A. Jasaitis, and V. P. Skulachev, “Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria,” Nature, vol. 222, no. 5198, pp. 1076–1078, 1969. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. N. Antonenko, A. V. Avetisyan, L. E. Bakeeva et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies,” Biochemistry, vol. 73, no. 12, pp. 1273–1287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. V. V. Neroev, M. M. Archipova, L. E. Bakeeva et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals,” Biochemistry, vol. 73, no. 12, pp. 1317–1328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. V. P. Skulachev, Y. N. Antonenko, D. A. Cherepanov et al., “Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs),” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1797, no. 6-7, pp. 878–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. V. Lokhmatikov, N. E. Voskoboynikova, D. A. Cherepanov et al., “Prevention of peroxidation of cardiolipin liposomes by quinol-based antioxidants,” Biochemistry, vol. 79, no. 10, pp. 1081–1100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. N. Lukashev, M. V. Skulachev, V. Ostapenko, A. Y. Savchenko, V. V. Pavshintsev, and V. P. Skulachev, “Advances in development of rechargeable mitochondrial antioxidants,” Progress in Molecular Biology and Translational Science, vol. 127, pp. 251–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “The mouse model of collagen-induced arthritis,” Methods in Molecular Medicine, vol. 102, pp. 295–312, 2004. View at Google Scholar · View at Scopus
  18. E. F. Rosloniec, M. Cremer, A. Kang, and L. K. Myers, “Collagen-induced arthritis,” Current Protocols in Immunology, vol. 89, pp. 15.5.1–15.5.25, 2001. View at Google Scholar
  19. Y. Li, S. Wang, Y. Wang et al., “Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway,” Translational Research, vol. 161, no. 2, pp. 89–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Brenner, H.-C. Meng, N. C. Yarlett et al., “The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage,” Arthritis & Rheumatism, vol. 52, no. 1, pp. 322–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. I. I. Galkin, O. Y. Pletjushkina, R. A. Zinovkin et al., “Mitochondria-targeted antioxidants prevent TNFα-induced endothelial cell damage,” Biochemistry, vol. 79, no. 2, pp. 124–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Brenner, H.-C. Meng, N. C. Yarlett et al., “The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane-induced arthritis,” The Journal of Immunology, vol. 174, no. 12, pp. 7894–7903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. H. Yu, J. K. Yi, H. S. Yuh et al., “Over-expression of extracellular superoxide dismutase in mouse synovial tissue attenuates the inflammatory arthritis,” Experimental & Molecular Medicine, vol. 44, no. 9, pp. 529–535, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-G. Wang, W.-D. Xu, W.-T. Zhai et al., “Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study,” Arthritis and Rheumatism, vol. 64, no. 4, pp. 993–1004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Jonsson, F. A. Wollheim, and B. Svensson, “No effect of acetylcystein on refractory rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 4, no. 4, pp. 363–364, 1986. View at Google Scholar
  26. M. N. Valcárcel-Ares, R. R. Riveiro-Naveira, C. Vaamonde-García et al., “Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytes,” Rheumatology, vol. 53, no. 7, pp. 1332–1343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. M. De Bandt, M. Grossin, F. Driss, J. Pincemail, C. Babin-Chevaye, and C. Pasquier, “Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 46, no. 2, pp. 522–532, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Tschopp and K. Schroder, “NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?” Nature Reviews Immunology, vol. 10, no. 3, pp. 210–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dashdorj, K. R. Jyothi, S. Lim et al., “Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines,” BMC Medicine, vol. 11, no. 1, article 178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. V. P. Romashchenko, I. I. Galkin, V. V. Zakharova et al., “Mitochondria-targeted compounds decrease TNF-a-dependent endothelium activation,” FEBS Journal, vol. 280, supplement 1, p. 246, 2013. View at Google Scholar
  31. R. E. Simmonds and B. M. Foxwell, “Signalling, inflammation and arthritis: NFκB and its relevance to arthritis and inflammation,” Rheumatology, vol. 47, no. 5, pp. 584–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Hultqvist, L. M. Olsson, K. A. Gelderman, and R. Holmdahl, “The protective role of ROS in autoimmune disease,” Trends in Immunology, vol. 30, no. 5, pp. 201–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. A. Gelderman, M. Hultqvist, J. Holmberg, P. Olofsson, and R. Holmdahl, “T cell surface redox levels determine T cell reactivity and arthritis susceptibility,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 34, pp. 12831–12836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Zhang, M. Raoof, Y. Chen et al., “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 7285, pp. 104–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. V. Skulachev, Y. N. Antonenko, V. N. Anisimov et al., “Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies,” Current Drug Targets, vol. 12, no. 6, pp. 800–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Srinivasan and N. G. Avadhani, “Hypoxia-mediated mitochondrial stress in RAW264.7 cells induces osteoclast-like TRAP-positive cells,” Annals of the New York Academy of Sciences, vol. 1117, pp. 51–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. X.-C. Bai, D. Lu, A.-L. Liu et al., “Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast,” The Journal of Biological Chemistry, vol. 280, no. 17, pp. 17497–17506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Hyeon, H. Lee, Y. Yang, and W. Jeong, “Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation,” Free Radical Biology and Medicine, vol. 65, pp. 789–799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. H.-J. Moon, W.-K. Ko, S. W. Han et al., “Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation,” Biochemical and Biophysical Research Communications, vol. 418, no. 2, pp. 247–253, 2012. View at Publisher · View at Google Scholar · View at Scopus